Increased sensitivity to anticancer reagents including 5-fluorouracil and cisplatin, and irradiation has been observed in METTL3-depleted pancreatic cancer cells [35], which is consistent with our findings showing that METTL3 knockdown could enhance the sensitivity of AML cells to chemotherapy. This evidence concerns the gene METTL3 and familial pancreatic carcinoma.